Stephen C. Fireng - 24 Apr 2024 Form 3 Insider Report for Keypath Education International, Inc.

Role
Director & Global CEO, Director
Signature
/s/ Eric Israel, attorney-in-fact
Issuer symbol
N/A
Transactions as of
24 Apr 2024
Net transactions value
$0
Form type
3
Filing time
24 Apr 2024, 21:40:38 UTC
Next filing
12 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding Common Stock 9,521,783 24 Apr 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding Stock Option (Right to Buy) 24 Apr 2024 Common Stock 1,424,561 $2.87 Direct F3
holding Restricted Stock Units 24 Apr 2024 Common Stock 1,352,450 Direct F4, F5
holding Restricted Stock Units 24 Apr 2024 Common Stock 450,817 Direct F4, F5, F6
holding Restricted Stock Units 24 Apr 2024 Common Stock 800,000 Direct F4, F5
holding Restricted Stock Units 24 Apr 2024 Common Stock 1,500,000 Direct F4, F5, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of shares of common stock, par value $0.01 per share ("Common Stock"), of Keypath Education International, Inc. (the "Issuer") underlying issued and outstanding CHESS Depositary Interests ("CDIs") that are listed by the Issuer for trading on the Australian Securities Exchange (the "ASX"). CDIs are convertible at the option of the holder thereof into shares of Common Stock on a 1-for-1 basis.
F2 Includes 2,340,605 CDIs of the Issuer subject to voluntary escrow and will be released from escrow upon the announcement of the Company's results for the year ending June 30, 2024.
F3 The exercise price of AUD3.71 per share is reported in column 4 in U.S. Dollars using a foreign exchange rate of 1 U.S. Dollar to 1.29366 Australian Dollars on the grant date. Once exercisable, each stock option may be exercised to purchase CDIs pursuant to the terms and conditions set forth in the Stock Option Award Agreement, dated as of May 10, 2021, by and between the Issuer and the Reporting Person.
F4 Not applicable.
F5 The restricted stock units ("RSUs") were granted under the 2021 Equity Incentive Plan of the Issuer. Each RSU represents a contingent right to receive one CDI as of the vesting date.
F6 The Reporting Person was awarded 676,225 RSUs on November 30, 2022, of which 225,408 vested on September 1, 2023, 225,408 will vest on September 1, 2024, and 225,409 will vest on September 1, 2025.
F7 The Reporting Person was awarded 1,500,000 RSUs on November 30, 2023, which will vest in three equal annual installments beginning on September 1, 2024.

Remarks:

Exhibit 24.1 - Power of Attorney